Publication | Closed Access

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy

Cell AutophagyBreast OncologyMedicineImmunologyAutophagyCell DeathCardiac ToxicityBreast CancerAnti-cancer AgentCancer TreatmentOncologyCell BiologyTumor MicroenvironmentCancer Growth